Thus, tumor promoting ability of fibroblasts did not depend on their tissue source of origin (i.e. breast tumor or reduction mammoplasty, Table 1), nor did it associate with their extent of αSMA, FSP, FAP, or Caveolin-1 expression (Fig. 1 and Fig. S1A). The gene discussed is FAP; the disease is breast neoplasm.